A new study reveals that pediatric neuroblastoma patients are at elevated risk for long-term psychological impairment. In addition, those who experience such impairment as they get older tend to require special education services and to not go on to college. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
In the United States, neuroblastoma–a childhood cancer of nerve cells–is diagnosed at a median age of 17.3 months. Treatment advances in recent years have prolonged survival for many affected children, but their young age at diagnosis and the specific therapies they receive can make them vulnerable to health problems as their central nervous system develops.
To assess the long-term psychological effects of neuroblastoma and its treatment, Nina Kadan-Lottick, MD, MSPH, of Yale University School of Medicine and her colleagues studied 859 children who had been diagnosed with neuroblastoma at least five years earlier and were under 18 years old. Their median age at diagnosis was 0.8 years, and they were followed for a median of 13.3 years. These 859 neuroblastoma survivors were compared with 872 siblings of childhood cancer survivors.
Compared with siblings, neuroblastoma survivors had an increased prevalence of impairment in the domains of anxiety/depression (19 percent versus 14 percent), headstrong behavior (19 percent versus 13 percent), attention deficits (21 percent versus 13 percent), peer conflict/social withdrawal (26 percent versus 17 percent), and antisocial behavior (16 percent versus 12 percent).
Common treatments–vincristine, cisplatin, and retinoic acid–were not associated with impairment, but survivors who developed chronic health conditions as a result of their cancer treatment were at higher risk for developing worse outcomes. Specifically, developing pulmonary disease was linked with an increased risk of impairment in all five domains, and developing endocrine disease and peripheral neuropathy were each linked with impairment in three domains. In addition, survivors who experienced psychological impairment tended to require special education services and to not go on to college.
"These findings are novel because this is the first large study that could look at how neuroblastoma patients are doing in terms of psychological and educational outcomes. Before recent advances in treatment, this survivor population was much smaller and we were not able to analyze these sorts of long-term outcomes," said Dr. Kadan-Lottick. "The goal is not simply to get our patients to be cancer-free but also to optimize their mental, emotional, and social functioning as they move into adolescence and adulthood. Our hope is that these findings will help inform strategies for early screening and intervention to identify those survivors at highest risk for developing psychological and educational impairment later on in life."
June is National Cancer Survivors month.
###
Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:
Dawn Peters (US) +1 781-388-8408
[email protected]
Follow us on Twitter @WileyNews
Full Citation: "Long-term psychological and educational outcomes in survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Daniel J. Zheng, Kevin R. Krull, Yan Chen, Lisa Diller, Yutaka Yasui, Wendy Leisenring, Pim Brouwers, Rebecca Howell, Jin-Shei Lai, Lyn Balsamo, Kevin C. Oeffinger, Leslie L. Robison, Gregory T. Armstrong, and Nina S. Kadan-Lottick. CANCER; Published Online: June 11, 2018 (DOI: 10.1002/cncr.31379).
URL Upon Publication: http://doi.wiley.com/10.1002/cncr.31379
Note: some of the data included in the article were presented as an oral presentation at the 15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer: June 15-17, 2017; Atlanta, Georgia.
Author Contact: Karen Peart, of Yale University's Office of Public Affairs & Communications, at [email protected] or +1 203-432-1326.
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.
Follow us on Twitter @JournalCancer
About Wiley
Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com
Media Contact
Dawn Peters
[email protected]
781-388-8408
http://newsroom.wiley.com/
http://dx.doi.org/10.1002/cncr.31379
